RNSH Surgery & Anaesthesia Research Activity Report 21-22

CURRENT RESEARCH ACTIVITY

• Clinical and laboratory-based research in melanoma and breast cancer • Retrospective study on loco-regional recurrence and functional outcomes following axillary treatment in early node positive breast cancer • Outcomes of targeted axillary clearance in early node positive breast cancer following neoadjuvant chemotherapy • Breast screening in patients with neurofibromatosis • Staging investigations in high-risk patients and their subsequent follow-up • Development of a multidisciplinary and functional breast database for northern campus

PUBLICATIONS

2022

Dempsey et al. 2022 “Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study.” BMJ Open 12: e066852 PMID:36600423 Surgical Staff: Andrew Spillane Winder et al. 2022 “Radio-isotope occult lesion localization (ROLL) techniques to identify the clipped node for targeted axillary dissection (TAD) in breast cancer.” ANZ J Surg 92: 3017-3021 PMID:36262092 Surgical Staff: Andrew Spillane, Samriti Sood, Kylie Snook Smith et al. 2022 “Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework.” Implement Sci Commun 3: 103 PMID:36183121 Surgical Staff: Andrew Spillane Simpson et al. 2022 “Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome.” Nat Med 28: 2344-2352 PMID:36138151 Surgical Staff: Andrew Spillane Newell et al. 2022 “Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.” Cancer Discov 12: 2856-2879 PMID:36098958 Surgical Staff: Andrew Spillane Conway et al. 2022 “Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites.” J Immunother Cancer 10: e004884 PMID:36096531 Surgical Staff: Andrew Spillane Seviiri et al. 2022 “Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting.” J Transl Med 20: 403 PMID:36064556 Surgical Staff: Andrew Spillane Lawless et al. 2022 “ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases.” Ann Surg Oncol 29: 7031-7032 PMID:35994160 Surgical Staff: Andrew Spillane Ofri et al. 2022 “Synchronous Operable Pancreatic and Breast Cancer Without Genetic Mutation: A Literature Review and Discussion.” Front Surg 9: 858349 PMID:35813042 Surgical Staff: Samriti Sood, Jaswinder Samra, Anubhav Mittal Lawless et al. 2022 “Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases.” Ann Surg Oncol 29: 7019-7028 PMID:35771368 Surgical Staff: Andrew Spillane Reijers et al. 2022 “Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.” Nat Med 28: 1178-1188 PMID:35661157 Surgical Staff: Andrew Spillane van Akkooi et al. 2022 “Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).” Ann Surg Oncol 29: 5241-5242 PMID:35426590 Surgical Staff: Andrew Spillane Metz et al. 2022 “Breast Radiotherapy after Oncoplastic Surgery-A Multidisciplinary Approach.” Cancers (Basel) 14: 1685 PMID:35406457 Surgical Staff: Kylie Snook, Samriti Sood, Andrew Spillane El Sharouni et al. 2022 “Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.” Eur J Cancer 167: 123-132 PMID:35256245 Surgical Staff: Andrew Spillane El Sharouni et al. 2022 “Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.” Eur J Cancer 167: 133-141 PMID:35216870 Surgical Staff: Andrew Spillane

6

Made with FlippingBook - professional solution for displaying marketing and sales documents online